KemOne ranked among the top searched stocks for 4 days in the past month.


As of 2:30 PM on the 9th, KemOne is trading at 4,710 KRW, up 1.29% from the previous day. This represents a 54.43% increase compared to October 23. KemOne is known as Korea's first non-clinical CRO company.

Over the past 5 days, individual investors have sold a net 673,333 shares, while foreigners and institutions have bought a net 510,846 shares and 228,343 shares, respectively.


On November 4, KemOne was a market topic with the headline "KemOne weak despite AstraZeneca's vaccine production news for March next year."



※Source: AI Investment Assistant AI Lassiro


※ This article was generated in real-time by an automatic article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing